Embecta (EMBC) Profit After Tax Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 16.74% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -123.42% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 9.23% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 54.57% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 25.41% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 20.96% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -113.49% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | -7.61% |
| 10 | Embecta | 197.17 Mn | 3.77 Mn | 127.80 Mn | -117.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -117.45% |
| Sep 30, 2025 | 80.82% |
| Jun 30, 2025 | 209.52% |
| Mar 31, 2025 | -18.69% |
| Sep 30, 2024 | 143.33% |
| Jun 30, 2024 | -3.29% |
| Mar 31, 2024 | 106.43% |
| Dec 31, 2023 | -42.90% |
| Sep 30, 2023 | 134.88% |
| Jun 30, 2023 | -75.64% |
| Mar 31, 2023 | -82.41% |
| Dec 31, 2022 | -64.37% |
| Sep 30, 2022 | -117.75% |
| Jun 30, 2022 | -40.40% |
| Mar 31, 2022 | -26.23% |
| Dec 31, 2021 | -6.17% |